Written Question·Department of Health and Social Care·UIN HL1994

Migraines: Drugs

Tabled: 13 July 2026

Answered: 20 July 2026

Question

To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 6 July (HL1488), how the Medicines and Healthcare products Regulatory Agency will communicate the conclusions of its review of mental health risks for migraine prophylaxi

Answer

The Medicines and Healthcare products Regulatory Agency (MHRA) is an executive agency of the Department with responsibility for ensuring medicines meet appropriate standards of quality, efficacy, and safety.The MHRA has plans to gather the currently avail...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN HL1994) →